Daxor Corporation (DXR) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Daxor Corporation (DXR) closed at USD 10.09 on 2026-10-14, a change of -22.4 % over the past year, with a market capitalization of USD 59.55M.

Daxor Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Daxor Corporation key figures

Previous close

USD 10.09 (2026-10-14)

1-year change

-22.4 %

Market cap

USD 59.55M

Enterprise value

n/a

P/E ratio (trailing)

9.44

P/E ratio (forward)

n/a

EPS (trailing)

1.08

EPS (forward)

n/a

PEG ratio

n/a

Price to book

1.15

Revenue growth

25.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.16

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Daxor Corporation and compare it with other stocks.